Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer 2025-11-20 18:52
Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs 2025-11-20 10:56
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry 2025-11-20 10:00
BIOVOZ and the University of Auckland Join Forces to Lead the Next Frontier in Anti-Aging Research 2025-11-19 15:02
Lynk Pharmaceuticals Announces Key Phase II Clinical Results of LNK01004 for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis 2025-11-19 08:00
CRScube acquires Mednet to expand global eClinical capabilities 2025-11-18 17:00
INSTITUTE OF NEURODIVERSITY, NEUROPOWER WORLD, AND SINGAPORE BRINGS NEURODESIGN TO THE FOREFRONT OF SINGAPORE'S URBAN PLANNING 2025-11-18 09:00
Ajinomoto Bio-Pharma Services Wins "Best ADC Preclinical Publication 2024" Award for AJICAP® Technology at 2025 World ADC Awards 2025-11-17 22:26
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US 2025-11-17 22:06
AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment 2025-11-17 13:45
Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine 2025-11-14 17:43
Amorepacific Named CES Innovation Award Honoree for Advanced Electronic Skin Platform 2025-11-14 09:00
Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal 2025-11-14 09:00
KHB Showcases the Enhanced FOCUS PEGASUS MF200 -- Redefining Efficiency in Veterinary Diagnostics 2025-11-13 15:18
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A 2025-11-12 16:12
/C O R R E C T I O N -- Heng Ren Partners/ 2025-11-12 12:31
Alpha IVF Singapore uses Advanced Fertility Genomic Screening and Artificial Intelligence Embryo Scoring to help couples become parents 2025-11-12 10:00
OPALESCENCE Trial Published in EJNMMI: Confirms Theranostic Potential of TLX250-CDx in Breast Cancer 2025-11-12 04:00
Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments 2025-11-12 03:11
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine 2025-11-11 21:01
1 2 3 4 5 264